Growth Metrics

Alnylam Pharmaceuticals (ALNY) EPS (Basic) Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Revolution Medicines 32.39 Bn 32.39 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 45.92%
Dec 31, 2025 35.72%
Sep 30, 2025 37.07%
Jun 30, 2025 39.39%
Mar 31, 2025 58.79%
Dec 31, 2024 32.99%
Sep 30, 2024 20.32%
Jun 30, 2024 56.78%
Mar 31, 2024 32.75%
Dec 31, 2023 19.51%
Sep 30, 2023 36.46%
Jun 30, 2023 -12.31%
Mar 31, 2023 4.75%
Dec 31, 2022 12.06%
Sep 30, 2022 -20.03%
Jun 30, 2022 -4.27%
Mar 31, 2022 -4.95%
Dec 31, 2021 -1.10%
Sep 30, 2021 10.88%
Jun 30, 2021 0.41%
Mar 31, 2021 -6.64%
Dec 31, 2020 -12.19%
Sep 30, 2020 -17.61%
Jun 30, 2020 -5.20%
Mar 31, 2020 -9.03%
Dec 31, 2019 -23.23%
Sep 30, 2019 -16.64%
Jun 30, 2019 -24.37%
Mar 31, 2019 -12.66%
Dec 31, 2018 -25.00%
Sep 30, 2018 -38.74%
Jun 30, 2018 -24.24%
Mar 31, 2018 -31.51%
Dec 31, 2017 -74.19%
Sep 30, 2017 -32.20%
Jun 30, 2017 -32.20%
Mar 31, 2017 30.35%
Dec 31, 2016 -37.30%
Sep 30, 2016 -36.10%
Jun 30, 2016 -53.55%
Mar 31, 2016 -100.55%
Dec 31, 2015 3.75%
Sep 30, 2015 -33.79%
Jun 30, 2015 -50.37%
Mar 31, 2015 -35.36%
Dec 31, 2014 5.33%
Sep 30, 2014 -23.22%
Jun 30, 2014 -20.68%
Mar 31, 2014 -113.54%
Dec 31, 2013 -44.22%
Sep 30, 2013 -27.79%
Jun 30, 2013 6.08%
Dec 31, 2012 -85.78%